MoneyWorks4Me

Revenue showed a marginal decline at Rs. 1.71 millions. For the quarter ended September 2024, as compared to corresponding quarter of last year.The Net Loss for the quarter ended September 2024 is Rs. -3.05 millions as compared to Net Loss of Rs. -0.28 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 further decreased to -3.02% as compared to -0.26% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1.71 0.00 0.00 2.75 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.30 0.50 -40.00 1.99 4.19 -52.51
PBIDT -3.02 -0.26 1061.54 -2.90 -0.06 4733.33 0.95 2.34 -59.40
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
PBDT -3.03 -0.26 1065.38 -2.91 -0.06 4750.00 0.95 2.34 -59.40
Depreciation 0.02 0.02 0.00 0.04 0.04 0.00 0.07 0.08 -12.50
PBT -3.05 -0.28 989.29 -2.95 -0.10 2850.00 0.88 2.26 -61.06
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -3.05 -0.28 989.29 -2.95 -0.10 2850.00 0.66 2.26 -70.80
Equity 52.39 52.39 0.00 52.39 52.39 0.00 52.39 52.39 0.00
PBIDTM(%) -176.61 0.00 0.00 -105.45 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..